Literature DB >> 26542056

Resident Memory T Cells as Surrogate Markers of the Efficacy of Cancer Vaccines.

Mevyn Nizard1, Hélène Roussel1, Eric Tartour2.   

Abstract

Cancer vaccine boost via the cervicovaginal rather than the intramuscular route of immunization appears to be crucial to induce genital CD8(+) T cells and tumor regression. This clinical activity is correlated with the ability of the mucosal boost to elicit resident memory T cells in the genital tract. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26542056     DOI: 10.1158/1078-0432.CCR-15-2364

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  15 in total

1.  Tissue-resident memory T cells play a key role in the efficacy of cancer vaccines.

Authors:  C Granier; C Blanc; S Karaki; T Tran; H Roussel; E Tartour
Journal:  Oncoimmunology       Date:  2017-08-08       Impact factor: 8.110

Review 2.  Therapeutic cancer vaccine: building the future from lessons of the past.

Authors:  T Tran; C Blanc; C Granier; A Saldmann; C Tanchot; Eric Tartour
Journal:  Semin Immunopathol       Date:  2018-07-05       Impact factor: 9.623

Review 3.  Tissue-Resident T Cells and Other Resident Leukocytes.

Authors:  David Masopust; Andrew G Soerens
Journal:  Annu Rev Immunol       Date:  2019-02-06       Impact factor: 28.527

4.  Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells.

Authors:  Clémence Granier; Emeline Vinatier; Elia Colin; Marion Mandavit; Charles Dariane; Virginie Verkarre; Lucie Biard; Rami El Zein; Corinne Lesaffre; Isabelle Galy-Fauroux; Hélène Roussel; Eléonore De Guillebon; Charlotte Blanc; Antonin Saldmann; Cécile Badoual; Alain Gey; Éric Tartour
Journal:  J Vis Exp       Date:  2018-02-08       Impact factor: 1.355

Review 5.  Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors.

Authors:  Soumaya Karaki; Marie Anson; Thi Tran; Delphine Giusti; Charlotte Blanc; Stephane Oudard; Eric Tartour
Journal:  Vaccines (Basel)       Date:  2016-11-03

6.  Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells.

Authors:  Michel Enamorado; Salvador Iborra; Elena Priego; Francisco J Cueto; Juan A Quintana; Sarai Martínez-Cano; Ernesto Mejías-Pérez; Mariano Esteban; Ignacio Melero; Andrés Hidalgo; David Sancho
Journal:  Nat Commun       Date:  2017-07-17       Impact factor: 14.919

7.  Induction of resident memory T cells enhances the efficacy of cancer vaccine.

Authors:  Mevyn Nizard; Hélène Roussel; Mariana O Diniz; Soumaya Karaki; Thi Tran; Thibault Voron; Estelle Dransart; Federico Sandoval; Marc Riquet; Bastien Rance; Elie Marcheteau; Elizabeth Fabre; Marion Mandavit; Magali Terme; Charlotte Blanc; Jean-Baptiste Escudie; Laure Gibault; Françoise Le Pimpec Barthes; Clemence Granier; Luis C S Ferreira; Cecile Badoual; Ludger Johannes; Eric Tartour
Journal:  Nat Commun       Date:  2017-05-24       Impact factor: 14.919

Review 8.  The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin.

Authors:  Stéphanie Corgnac; Marie Boutet; Maria Kfoury; Charles Naltet; Fathia Mami-Chouaib
Journal:  Front Immunol       Date:  2018-08-15       Impact factor: 7.561

9.  Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours.

Authors:  Lukasz Bialkowski; Alexia van Weijnen; Kevin Van der Jeught; Dries Renmans; Lidia Daszkiewicz; Carlo Heirman; Geert Stangé; Karine Breckpot; Joeri L Aerts; Kris Thielemans
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

Review 10.  Resident memory T cells, critical components in tumor immunology.

Authors:  Fathia Mami-Chouaib; Charlotte Blanc; Stéphanie Corgnac; Sophie Hans; Ines Malenica; Clémence Granier; Isabelle Tihy; Eric Tartour
Journal:  J Immunother Cancer       Date:  2018-09-04       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.